Press and News Items

support_agent

Your contact persons

CHEPLAPHARM Arzneimittel GmbH

Welcome to our news section. This is where we provide you with first hand news and information from and about CHEPLAPHARM. We offer you a broad range of current information and materials for all publishing needs. All texts and images are free to use for editorial purposes.

Press

Our News

View:
format_list_bulletedgrid_view

10/25/2022

CHEPLAPHARM receives growth capital of €550 Million from two leading global investors
Press releases
Read morechevron_right

08/29/2022

CHEPLAPHARM increases revenue and earnings in the first half of 2022
Press releases
Read morechevron_right

06/01/2022

CHEPLAPHARM strengthens its oncology portfolio
Press releases
Read morechevron_right

05/16/2022

CHEPLAPHARM acquires rights to CMV medicine
Press releases
Read morechevron_right

04/29/2022

CHEPLAPHARM continues profitable growth track in 2021 as well
Press releases
Read morechevron_right

03/21/2022

Significant and sustainable site expansion
Press releases
Read morechevron_right

03/01/2022

CHEPLAPHARM acquires additional oncology drugs
Press releases
Read morechevron_right

02/23/2022

Jens Rothstein hands over his CFO role to Kia Parssanedjad
Press releases
Read morechevron_right

02/11/2022

CHEPLAPHARM announces successful pricing of Term Loan B
Investor Relations
Read morechevron_right

Archive

Back to topexpand_less